Şunu aradınız:: bioekwivalenza (Maltaca - İngilizce)

bio-disponibilità /bioekwivalenza
bioavailability/bioequivalence

studju ta 'bioekwivalenza qabbel trizivir ma' 300 mg abacavir, 150 mg lamivudine u 300 mg zidovudine meħuda flimkien.
a bioequivalence study compared trizivir with abacavir 300 mg, lamivudine 150 mg and zidovudine 300 mg taken together.

studju dwar bioekwivalenza qabbel lil combivir ma 'pilloli ta' 150 mg lamivudine u ta '300mg zidovudine meħudin flimkien.
a bioequivalence study compared combivir with lamivudine 150 mg and zidovudine 300 mg tablets taken together.

madankollu, il-bioekwivalenza ta’eucreas meta ngħata flimkien ma’ vildagliptin u metformin ġiet murija (ara sezzjoni 5.2).
however, bioequivalence of eucreas with co-administered vildagliptin and metformin has been demonstrated (see section 5.2).

intweriet bioekwivalenza mejn eucreas fi tlett qawwiet ta’ dożi (50 mg/500 mg, 50 mg/850 mg u 50 mg/1000 mg), kontra kombinazzjoni ħielsa ta’ pilloli ta’ vildagliptin u metformin hydrochloride bid-dożi li jikkorrispondu għalihom.
bioequivalence has been demonstrated between eucreas at three dose strengths (50 mg/500 mg, 50 mg/850 mg and 50 mg/1000 mg) versus free combination of vildagliptin and metformin hydrochloride tablets at the corresponding doses.